pill

Sector Update: Health Care

Published on Mon, 04/04/2011 - 14:13
By FNNO Staff in General Interest, abt, kkr, PFE, abbott labs, abt, business, capsugel, cash, clinical, disease, drug, health, kohlberg kravis roberts, krr, medication, patient, pfe, pfizer, pharm, pill, revenue, sector, shares, treatment, Health & Pharma Report
abbott labs, abt, business, capsugel, cash, clinical, disease, drug, health, kohlberg kravis roberts, krr, medication, patient, pfe, pfizer, pharm, pill, revenue, sector, shares, treatment

Health care shares are trending higher, while Abbott Laboratories (ABT) is seeing solid gains after reporting study results. In sector news, Abbott Laboratories (ABT) today announced that data from its Endovascular Valve Edge-to-E

By FNNO Staff
fnnonline@gmail.com

Vivus Adds 12% in Early Trading on Qnexa Study Results

Published on Mon, 04/04/2011 - 10:56
By FNNO Staff in General Interest, VVUS, blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss, News Update
blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss

Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug QNEXA for two years showed reductions in blood pressure and the use of antihypertensive

By FNNO Staff
fnnonline@gmail.com

Health Care Sector Report: February 28th, 2011

Published on Mon, 02/28/2011 - 14:50
By Stephanie Shyu in General Interest, JNJ, MYL, PFE, approval, australia, defects, device, disease, drug, fda, gabapentin, generic, health, healthcare, high school, hip replacement, jnj, johnson & johnson, lawsuit, matrix labs, medical, myl, mylan, neurontin, patients, pfizer, pharma, pill, sector, shingles, subsidiary, sue, tasmania, teacher, treatment, Health & Pharma Report
approval, australia, defects, device, disease, drug, fda, gabapentin, generic, health, healthcare, high school, hip replacement, jnj, johnson & johnson, lawsuit, matrix labs, medical, myl, mylan, neurontin, patients, pfizer, pharma, pill, sector, shingles, subsidiary, sue, tasmania, teacher, treatment

Health care shares are higher Monday. Bloomberg is reporting that a high school teacher in Tasmania is suing Johnson & Johnson over an implanted hip-replacement device that stopped selling in Australia due to defects. Meanwhil

By Stephanie Shyu
sshyu@fnno.com

Teva Pharmaceuticals Down 0.9% Despite Positive Results from Phase III Trial of Rhinits Drug

Published on Wed, 02/09/2011 - 13:41
By Christie Duffy in aid, allergy, analyst, approval, cure, drug, fda, General Interest, government, industry, patient, pharmaceutical, phase, pill, review, rhinits, sector, share, sick, stock, test, teva, trade, trial, teva, aid, allergy, analyst, approval, cure, drug, fda, government, industry, patient, pharmaceutical, phase, pill, review, rhinits, sector, share, sick, stock, test, teva, trade, trial, News Update

Teva said results from a Phase III study of QNAZE HFA, its nasal aerosol corticosteroid in development to treat perennial allergic rhinitis (PAR) and seasonal allergic rhinitis, achieved all primary and secondary efficacy endpoint

Teva shares are down 0.9%, or $0.46, to $51.56.

teva, pharmaceutical, pill, drug, test, trial, fda, review, government, approval, patient, cure, aid, sick, allergy, share, trade, stock, sector, industry, analyst, phase, rhinits

Teva Pharmaceuticals (TEVA) shares are down fractionally, despite positive drug trial news.

By Christie Duffy
cduffy@fnno.com

Novo Nordisk Inks Insulin Pill Development Pact with Emisphe

Published on Tue, 12/21/2010 - 12:55
By FNN Staff in General Interest, emis, nvo, adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech
adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech

Novo Nordisk (NVO) ADRs are down after the company said it had signed a deal with Emisphere Technologies (EMIS) to use that firm's technology to develop an oral insulin pill, according to a company statement. Currently, there are

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News

  •
    01:10 PM MIDWEEK MARKET WRAP UP:New Report Expected to Shakeup Libor

    From FNNO.com, this is the Financial News Network. I’m Cleo
    Stiller-Farrell and this is your Midweek Market Wrap Up. The British
    Bankers’ Association, which has the supervisory role of setting the
    influential Libor rates, announced that it would be willing to give up
    its...

    +
  • 11:04 AM What's in the News for September 26, 2012

    The Wall Street Journal reports that home prices showed their best year-to-date gains since 2005, up 5.9% through July, signaling the housing market's steady march toward recovery. Also from the Wall Street Journal, IBM (IBM) will increase its efforts to sell so-called cloud computing services...

    +
  • 11:04 AM Yahoo Makes Ken Goldman New CFO

    CEO Marissa Mayer is bringing in some more new blood to Yahoo!, tapping Ken Goldman as the company's new Chief Financial Officer. Goldman's appointment will take effect on October 22nd.

    Goldman served as CFO at his most recent employer, Fortinet, having worked at Siebel Systems, Sybase,...

    +
More